Mavrommatis A C, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S
Department of Critical Care and Pulmonary Services, University of Athens Medical School, Evangelismos Hospital, Greece.
Crit Care Med. 2000 Feb;28(2):451-7. doi: 10.1097/00003246-200002000-00027.
To test the hypothesis that the coagulation system and platelets are activated in sepsis, the uncomplicated and usually earliest stage of the septic process, and to compare the findings detected in sepsis with those found in severe sepsis and septic shock.
Prospective study comparing patients with sepsis, severe sepsis, and septic shock, and healthy volunteers.
General intensive care unit in a tertiary university hospital.
Seventy-four consecutive septic patients (45 with sepsis, 15 with severe sepsis, and 14 with septic shock). Fourteen healthy volunteers served as control subjects.
None.
After blood sampling, molecular activation markers of coagulation (prothrombin fragments 1 and 2, fibrinopeptide A, thrombin-antithrombin complexes, and monomers of fibrin) and of platelets (beta-thromboglobulin and platelet factor 4), several coagulation factors, global tests of coagulation (prothrombin time and activated partial thromboplastin time), and platelet count (PTL) were measured. In sepsis, prothrombin fragments 1 and 2, fibrinopeptide A, thrombin-antithrombin complexes, and monomers of fibrin were increased to 2.52+/-0.21 nmol/L, 20.88+/-2.52 ng/mL, 33.8+/-2.9 microg/L, and 69% positive, respectively, compared with control subjects (0.86+/-063 nmol/L, 1.14+/-0.15 ng/mL, 16.07+/-1.01 microg/L, and 0%, respectively). Beta-Thromboglobulin and the beta-thromboglobulin-to-platelet factor 4 ratio were also increased to 107.87+/-11.87 IU/mL and 8.86+/-1.06, compared with controls (18.36 +/-2.99 IU/mL and 2.67+/-0.52, respectively). With the exception of a decrease in factor XII and an increase in fibrinogen, coagulation factors, global coagulation tests, and PTL were not changed in sepsis. In severe sepsis and mainly in septic shock, coagulation factors were markedly decreased, global coagulation tests were prolonged, and PTL was reduced. All changes were independent of the causative infectious pathogen.
Coagulation system and platelets are strongly activated in sepsis. In this stage, only factor XII is decreased. In contrast, in severe sepsis and mainly in septic shock, most of the coagulation factors are depleted, PTL is decreased, and global coagulation tests are prolonged, indicating exhaustion of hemostasis. Finally, Gram-positive, Gram-negative, and other microorganisms produce identical impairment of coagulation.
检验如下假设,即凝血系统和血小板在脓毒症(脓毒症过程中无并发症且通常为最早阶段)中被激活,并比较脓毒症患者与严重脓毒症和脓毒性休克患者的检测结果。
比较脓毒症、严重脓毒症和脓毒性休克患者及健康志愿者的前瞻性研究。
一所三级大学医院的综合重症监护病房。
74例连续性脓毒症患者(45例脓毒症患者、15例严重脓毒症患者和14例脓毒性休克患者)。14名健康志愿者作为对照。
无。
采血后,检测凝血分子激活标志物(凝血酶原片段1和2、纤维蛋白肽A、凝血酶-抗凝血酶复合物及纤维蛋白单体)和血小板激活标志物(β-血小板球蛋白和血小板第4因子)、几种凝血因子、凝血整体检测指标(凝血酶原时间和活化部分凝血活酶时间)以及血小板计数(PTL)。与对照组相比,脓毒症患者的凝血酶原片段1和2、纤维蛋白肽A、凝血酶-抗凝血酶复合物及纤维蛋白单体分别增至2.52±0.21 nmol/L、20.88±2.52 ng/mL、33.8±2.9 μg/L及阳性率69%(对照组分别为0.86±0.63 nmol/L、1.14±0.15 ng/mL、16.07±1.01 μg/L及0%)。β-血小板球蛋白及β-血小板球蛋白与血小板第4因子的比值也分别增至107.87±11.87 IU/mL及8.86±1.06,而对照组分别为(18.36±2.99 IU/mL及2.67±0.52)。除因子Ⅻ降低及纤维蛋白原增加外,脓毒症患者的凝血因子、凝血整体检测指标及PTL无变化。在严重脓毒症尤其是脓毒性休克患者中,凝血因子显著降低,凝血整体检测指标延长,PTL降低。所有变化均与致病感染病原体无关。
凝血系统和血小板在脓毒症中被强烈激活。在此阶段,仅因子Ⅻ降低。相比之下,在严重脓毒症尤其是脓毒性休克患者中,大多数凝血因子耗竭,PTL降低,凝血整体检测指标延长,提示止血功能衰竭。最后,革兰阳性菌、革兰阴性菌及其他微生物对凝血功能产生相同损害。